[(2R,3R,4S,5S,6R)-6-[(2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexoxy]-3,4,5-tri(pentanoyloxy)tetrahydropyran-2-yl]methyl pentanoate

ID: ALA4786586

PubChem CID: 162666857

Max Phase: Preclinical

Molecular Formula: C32H56O15

Molecular Weight: 680.78

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCCC(=O)OC[C@H]1O[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)[C@@H](OC(=O)CCCC)[C@@H](OC(=O)CCCC)[C@@H]1OC(=O)CCCC

Standard InChI:  InChI=1S/C32H56O15/c1-5-9-13-23(36)42-19-22-29(45-24(37)14-10-6-2)30(46-25(38)15-11-7-3)31(47-26(39)16-12-8-4)32(44-22)43-18-21(35)28(41)27(40)20(34)17-33/h20-22,27-35,40-41H,5-19H2,1-4H3/t20-,21-,22-,27-,28-,29-,30+,31+,32-/m1/s1

Standard InChI Key:  XGEUUBWQWGXLGP-NLBUCSMPSA-N

Molfile:  

 
     RDKit          2D

 47 47  0  0  0  0  0  0  0  0999 V2000
   31.8828  -14.7136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8828  -15.5349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5922  -15.9394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3017  -15.5349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3017  -14.7136    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.5922  -14.2967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0129  -15.9445    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.5922  -16.7607    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.1716  -15.9445    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.5922  -13.4754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1698  -14.3029    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.3041  -13.0668    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.0138  -16.7617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7219  -17.1695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7228  -17.9867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4309  -18.3946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4318  -19.2118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4292  -16.7602    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.0155  -18.3961    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.1382  -17.9852    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.1400  -19.6196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1408  -20.4368    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.7245  -19.6211    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.0108  -13.4772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7195  -13.0704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0087  -14.2944    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.4262  -13.4807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1689  -13.4857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4608  -13.0779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8762  -13.0764    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.7535  -13.4873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4643  -15.5352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7562  -15.9430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4652  -14.7180    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.0489  -15.5336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8845  -17.1693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8845  -17.9865    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.1768  -16.7607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4691  -17.1693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1349  -13.0739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0454  -13.0794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3408  -15.9415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7614  -16.7607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8416  -13.4843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3381  -13.4888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6335  -15.5321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0537  -17.1693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  4  7  1  1
  3  8  1  1
  2  9  1  1
  6 10  1  1
  1 11  1  6
 10 12  1  0
  7 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 14 18  1  1
 15 19  1  6
 16 20  1  6
 17 21  1  0
 21 22  1  0
 17 23  1  1
 12 24  1  0
 24 25  1  0
 24 26  2  0
 25 27  1  0
 11 28  1  0
 28 29  1  0
 28 30  2  0
 29 31  1  0
  9 32  1  0
 32 33  1  0
 32 34  2  0
 33 35  1  0
  8 36  1  0
 36 37  2  0
 36 38  1  0
 38 39  1  0
 27 40  1  0
 31 41  1  0
 35 42  1  0
 39 43  1  0
 40 44  1  0
 41 45  1  0
 42 46  1  0
 43 47  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4786586

    ---

Associated Targets(non-human)

Schizosaccharomyces pombe (495 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 680.78Molecular Weight (Monoisotopic): 680.3619AlogP: 1.20#Rotatable Bonds: 24
Polar Surface Area: 224.81Molecular Species: NEUTRALHBA: 15HBD: 5
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.59CX Basic pKa: CX LogP: 2.62CX LogD: 2.62
Aromatic Rings: Heavy Atoms: 47QED Weighted: 0.07Np Likeness Score: 1.06

References

1. Tsutsui N,Tanabe G,Ikeda N,Okamura S,Ogawa M,Miyazaki K,Kita A,Sugiura R,Muraoka O.  (2016)  Structure-activity relationship studies on acremomannolipin A, the potent calcium signal modulator with a novel glycolipid structure 4: Role of acyl side chains on d-mannose.,  121  [PMID:27243802] [10.1016/j.ejmech.2016.05.034]

Source